Literature DB >> 30370080

Towards a precision medicine in venous thromboembolism associated to lung cancer.

Luis Jara-Palomares1,2, Teresa Elias-Hernandez1, Maria Isabel Asensio-Cruz1, Samira Marin-Romero1, Remedios Otero-Candelera1.   

Abstract

Entities:  

Year:  2018        PMID： 30370080      PMCID： PMC6186635          DOI： 10.21037/jtd.2018.08.40

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  23 in total

Review 1.  International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancer.

Authors:  Dominique Farge; Henri Bounameaux; Benjamin Brenner; Francis Cajfinger; Philippe Debourdeau; Alok A Khorana; Ingrid Pabinger; Susan Solymoss; James Douketis; Ajay Kakkar
Journal:  Lancet Oncol       Date:  2016-10       Impact factor: 41.316

2.  A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score.

Authors:  S Barbar; F Noventa; V Rossetto; A Ferrari; B Brandolin; M Perlati; E De Bon; D Tormene; A Pagnan; P Prandoni
Journal:  J Thromb Haemost       Date:  2010-11       Impact factor: 5.824

3.  Frequency, demographics and risk (according to tumour type or site) of cancer-associated thrombosis among patients seen at outpatient DVT clinics.

Authors:  S Paneesha; A McManus; R Arya; N Scriven; T Farren; T Nokes; S Bacon; A Nieland; D Cooper; H Smith; D O'Shaughnessy; P Rose
Journal:  Thromb Haemost       Date:  2009-12-18       Impact factor: 5.249

Review 4.  Epidemiology of cancer-associated venous thrombosis.

Authors:  Jasmijn F Timp; Sigrid K Braekkan; Henri H Versteeg; Suzanne C Cannegieter
Journal:  Blood       Date:  2013-08-01       Impact factor: 22.113

5.  Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy.

Authors:  A A Khorana; C W Francis; E Culakova; N M Kuderer; G H Lyman
Journal:  J Thromb Haemost       Date:  2007-03       Impact factor: 5.824

6.  Venous thromboembolism after major cancer surgery: temporal trends and patterns of care.

Authors:  Vincent Q Trinh; Pierre I Karakiewicz; Jesse Sammon; Maxine Sun; Shyam Sukumar; Mai-Kim Gervais; Shahrokh F Shariat; Zhe Tian; Simon P Kim; Keith J Kowalczyk; Jim C Hu; Mani Menon; Quoc-Dien Trinh
Journal:  JAMA Surg       Date:  2014-01       Impact factor: 14.766

7.  Development and validation of a predictive model for chemotherapy-associated thrombosis.

Authors:  Alok A Khorana; Nicole M Kuderer; Eva Culakova; Gary H Lyman; Charles W Francis
Journal:  Blood       Date:  2008-01-23       Impact factor: 22.113

8.  Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis.

Authors:  Paolo Prandoni; Anthonie W A Lensing; Andrea Piccioli; Enrico Bernardi; Paolo Simioni; Bruno Girolami; Antonio Marchiori; Paola Sabbion; Martin H Prins; Franco Noventa; Antonio Girolami
Journal:  Blood       Date:  2002-07-12       Impact factor: 22.113

9.  Incidence of venous thromboembolism in patients with cancer - a cohort study using linked United Kingdom databases.

Authors:  Alex J Walker; Tim R Card; Joe West; Colin Crooks; Matthew J Grainge
Journal:  Eur J Cancer       Date:  2012-11-09       Impact factor: 9.162

Review 10.  Risk of venous thromboembolism in patients with cancer: a systematic review and meta-analysis.

Authors:  Freesia Horsted; Joe West; Matthew J Grainge
Journal:  PLoS Med       Date:  2012-07-31       Impact factor: 11.069
View more
  1 in total

1.  Anaplastic lymphoma kinase rearrangement may increase the incidence of venous thromboembolism by increasing tissue factor expression in advanced lung adenocarcinoma.

Authors:  Sen Yang; Li Yang; Yufeng Wu; Cuicui Zhang; Shuai Wang; Nan Ma; Li Wang; Qiming Wang
Journal:  Ann Transl Med       Date:  2020-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.